In prostate cancer fibroblast and tumor microenvironment models, AR activation has been linked to upregulation of MMP-9/VEGF signaling via PIP5K1α/AKT crosstalk, implicating a molecular axis by which androgen signaling promotes proteolysis and vascular remodeling in tumor stroma [136]. Here, MMP9 is linked to prostate cancer.